HEPATOPROTECTIVE EFFECTS OF CHOLECALCIFEROL AND N-ACETYLCYSTEINE IN ACETAMINOPHEN INDUCED HEPATOTOXICITY IN MICE
Abstract
Background: The liver is a critical factor that has a vital role in metabolism and excretion of various chemical substances and drugs. Liver harm is a major problem to health that challenges healthcare vendors and the pharmaceutical industry. Acute liver injuries caused by various toxic chemicals, drugs, high alcohol intake, and microbes are studied well. This study aimed to measure the out-turn of cholecalciferol in comparison to N-acetylcysteine in acetaminophen-induced hepatotoxicity in mice. Methods: It was an experimental randomized control trial carried out in the Department of Pharmacology, Islamic International Medical College in collaboration with National Institute of Health Islamabad. Forty adult Balb-C mice were divided into four groups with 10 mice in every group. Group 1 was the Negative control group, and the experimental groups 2, 3, and 4 were administered acetaminophen to set off hepatotoxicity which was confirmed after one week through measuring alanine transaminase (ALT) levels. Group 3 was then administered cholecalciferol, and group 4 was given N-acetylcysteine. Terminal sampling was done on day 28 to evaluate the results. Statistical analysis was accomplished on SPSS-22. Comparison among groups was done using one-way ANOVA and student’s t-test, and p<0.05 was taken statistically significant. Results: Mice of groups 3 and 4 significantly reduced ALT levels as compared to group 2. Cholecalciferol significantly decreased ALT levels in hepatotoxic mice with efficacy greater than N-acetylcysteine. Conclusion: Cholecalciferol is more efficacious in the reversal of acute liver injury as compared to N-acetylcysteine.
Pak J Physiol 2023;19(1):
References
Balaban YH, Aka C, Koca-Caliskan U. Liver immunology and herbal treatment. World J Hepatol 2017;9(17):757–70.
Lu J, Tang M, Zhang T. Review of toxicological effect of quantum dots on the liver. J Appl Toxicol 2019;39(1):72–86.
Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 2020;152:116–41.
Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, et al. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity. Clin Gastroenterol Hepatol 2017;15(10):1604–11.e1.
Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2020;5(2):167–228.
Chowdhury A, Nabila J, Adelusi Temitope I, Wang S. Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity. Pharmacol Res 2020;161:105102.
Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol 2018;17:274–83.
Al-Hashimi N, Abraham S. Cholecalciferol. StatPearls [Internet]. 2021 Jan 22. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK549768/ [cited 2021 Sep 16]
Elswefy SE, Abdallah FR, Wahba AS, Hasan RA, Atteia HH. Antifibrotic effect of curcumin, N-acetyl cysteine and propolis extract against bisphenol A-induced hepatotoxicity in rats: Prophylaxis versus co-treatment. Life Sci 2020;260:118245.
Sulaiman S, Hussain M, Nauman Shad M, Chiragh S. Hepatoprotective effect of Prazosin is comparable to N-Acetylcysteine in acetaminophen induced hepatotoxicity in mice. J Ayub Med Coll Abbottabad 2020;32(1):28–32.
Shendge AK, Panja S, Basu T, Ghate NB, Mandal N. Ameliorating effects of white mulberry on iron-overload-induced oxidative stress and liver fibrosis in Swiss albino mice. Food Chem Toxicol 2021;156:112520.
Dunn KW, Martinez MM, Wang Z, Mang HE, Clendenon SG, Sluka JP, et al. Mitochondrial depolarization and repolarization in the early stages of acetaminophen hepatotoxicity in mice. Toxicology. 2020;439:152464.
Anisiewicz A, Kowalski K, Banach J, Łabędź N, Stachowicz-Suhs M, Piotrowska A, et al. Vitamin D metabolite profile in cholecalciferol- or calcitriol-supplemented healthy and mammary gland tumor-bearing mice. Nutrient 2020;12(11):3416.
Munawar R, Jehangir A, Waheed A. Comparing hepatoprotective effects of aqueous extract of Cassia Fistula (Amaltas) leaves and silymarin. J Islamic Int Med Coll 2018;13(3):137–40.
Ltaif M, Gargouri M, Soussi A. Protective effects of A. Sativa against oxidative stress-induced liver damage in Ovariectomized mice. Biomed Res Int 2021 Jul 15;2021:5577498.
Kazemifar AM, Hajaghamohammadi AA, Samimi R, Alavi Z, Abbasi E, Asl MN. Hepatoprotective property of oral silymarin is comparable to N-Acetyl Cysteine in acetaminophen poisoning. Gastroenterology Res 2012;5(5):190–4.
Freitag AF, Cardia GF, da Rocha BA, Aguiar RP, Silva-Comar FM, Spironello RA, et al. Hepatoprotective effect of Silymarin (Silybum marianum) on hepatotoxicity induced by acetaminophen in spontaneously hypertensive rats. Evid Based Complement Alternat Med 2015;2015:538317.
Fahan Rashid HM, Syed U, Ahmad Z, Chauhdary KK, Musharraf U, Kumar S. Comparison of Different Formulations of Vitamin D. J Ayub Med Coll Abbottabad 2017;29(4):650–3.
Aliakbarian M, Nikeghbalian S, Ghaffaripour S, Bahreini A, Shafiee M, Rashidi M, et al. Effects of N-Acetylcysteine addition to the university of Wisconsin Solution on the rate of ischemia-reperfusion injury in adult orthotopic liver transplant. Exp Clin Transplant 2017;15(4):432–6.
El-Yamany MF, Zaki ES, Shaltout SA, Saad MA. Bone marrow mononuclear cells boost the anti-cytogentical aberration effect of N-acetylcysteine and α-lipoic acid in rat’s liver and bone marrow: implication of oxidative and inflammatory pathways. Toxicol Mech Methods 2021;31(6):437–49.
Targher G, Scorletti E, Mantovani A, Byrne CD. Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. Metab Syndr Relat Disord 2013;11(4):217–28.
Zhai LL, Zhu AK, Tang ZG. Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. Clin Nutr 2021;40(8):4845–6.
Özdemir-Kumral ZN, Erkek BE, Karakuş B, Almacı M, Fathi R, Yüksel M, et al. Potential effect of 1,25 dihydroxy vitamin D3 on thioacetamide-induced hepatotoxicity in rats. J Surg Res 2019;243:165–72.
Downloads
Copyright (c) 2023 Pakistan Journal of Physiology
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, cited and quoted with full reference of, and acknowledgement to the PJP.
